Fact CheckerSign in

NCT07527494Not yet recruiting

Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction

Source: ClinicalTrials.gov · Last updated 14 Apr 2026

Brief summary (registry, in English)

TWIN-SCD STEMI is a multicentric prospective, non-randomized pilot study designed to establish a multiparametric model for predicting life-threatening ventricular arrhythmias in patients experiencing their first myocardial infarction. The primary objective of the study is to develop an algorithm with superior predictive performance (sensitivity and specificity) compared to the currently used criterion for the implantation of a cardiac defibrillator, which is a left ventricular ejection fraction (LVEF) of less than 35%.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
1000 (estimated)
First submitted
7 Apr 2026
Start date
Apr 2026
Primary completion date
Dec 2033
Lead sponsor
University Hospital, Bordeaux
NCT number
NCT07527494

What you commit to

  • Study type: Interventional
  • Planned participants: 1000
  • From Apr 2026 to the primary completion date, Dec 2033
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • Renal failure (Creatinine clearance \<30 mL/min), or a systemic illness likely to limit survival to \<1 year

Other

  • Women who are pregnant, lactating, or who are planning to become pregnant within 2 years following her inclusion
  • Unable to understand the nature, risks, significance and implications of the clinical investigation or unwilling to provide written informed consent
  • Participant under legal protection

Who the study is looking for

  • History of ST-segment elevation myocardial infarction (STEMI) in the last 6 months
  • Signed informed consent
  • Affiliated to or beneficiary of a health insurance

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Bordeaux - Hôpital Cardiologique du Haut-Lévèque
Coordinator of this site? Confirm its status
PessacFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.